EMEA-000987-PIP01-10-M04

Key facts

Invented name
Strensiq
Active substance
asfotase alfa
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0176/2019
PIP number
EMEA-000987-PIP01-10-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hypophosphatasia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Alexion Europe SAS

Tel. +33 1 4710 0615
E-mail: pip.enquiries.eu@alexion.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating